ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FEB Functional Technologies Corp.

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Functional Technologies Corp. TSXV:FEB TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0 -

Functional Technologies Reports 2012 Financial Results

27/12/2012 11:00am

Marketwired Canada


Functional Technologies Corp. (TSX VENTURE:FEB)(OTCQX:FEBTF) (the "Company")
today reported operational and financial results for the year ended August 31,
2012. Amounts, unless specified otherwise, are expressed in Canadian dollars.
The Company's Consolidated Financial Statements have been prepared in accordance
with International Financial Reporting Standards.


"Functional Technologies Corp. has continued to make progress in the
commercialization of its core, proprietary technologies of acrylamide-preventing
(AP) and hydrogen sulphide (H2S)-preventing yeast platforms," said Mr.
Christopher Morris, Functional Technologies' interim Chief Executive Officer.
"The Company has also made substantial progress towards reducing costs, and
shedding non-core operations and assets."


Operating Highlights

During and subsequent to the period ended August 31, 2012, the Company announced:



--  The signing of an agreement with a leading global yeast producer, under
    which production of acrylamide-preventing yeast was to commence. Test-
    quantities of acrylamide-preventing yeast have been produced pursuant to
    this Material Transfer Agreement. 
--  That it has commenced evaluation food trials for a leading European
    producer of intermediary starch-based food products including extruded
    snack food pellets (the "Collaborator"), which are purchased and
    integrated by numerous downstream food manufacturers into a variety of
    other food products. These downstream food manufacturers represent many
    brand leaders in the processed food industries, and the Collaborator has
    established its global position over decades. 
--  That the U.S. Food and Drug Administration had accepted the Company's
    Generally Regarded As Safe Notice for its acrylamide-preventing yeast
    strains. 
--  The successful commercial launch of its new selectively bred
    Phyterra(TM)-branded hydrogen sulphide (H2S)-preventing wine yeast
    strains that have also been selected for low sulphur dioxide (SO2)
    production. 
--  That a New Zealand patent, and a notice of patent issuance in the United
    States, have been granted for the hydrogen sulphide ("H2S") preventing
    wine yeast technology licensed from the University of California. 



Financial Results

The Company incurred a net loss of $12.6 million during the period, compared to
$4.9 million for the year ended August 31, 2011. This increase is primarily the
result of the loss of $4.3m due to a non-cash impairment of the carrying value
of Phyterra Bio Inc. and Maritime Pulse Drying Inc. and a provision made for
$3.1m for the repayment of government assistance.


Liquidity and Outstanding Share Capital

As at August 31, 2012, the Company had cash and short-term investments of $0.4
million compared to $4.2 million as at August 31, 2011.


As at December 20, 2012, Functional Technologies Corp. had 61,370,444 common
shares issued and outstanding.


Additional Information

This news release should be read in conjunction with the Company's consolidated
financial statements for the year ended August 31, 2012 and the notes thereto,
together with the MD&A for the corresponding period, which are available on the
Company's website www.functionaltechcorp.com and on SEDAR at www.sedar.com.


About Functional Technologies Corp.

Functional Technologies develops and commercializes proprietary, advanced
yeast-based solutions to significant challenges in the food, beverage and
healthcare industries. The Company's platform improves the performance of innate
yeast functions, and prevents the formation of naturally occurring toxins and
contaminants that either affect final product quality or are classified by the
World Health Organization as probable human carcinogens. Functional
Technologies' lead technologies include yeasts that prevent and reduce the
formation of the foul-smelling hydrogen sulphide (H2S) and the carcinogens
acrylamide and ethyl carbamate (more commonly known as urethane), by-products of
food and beverage processing. These contaminants are found in many commonly
consumed items, such as fermented food products and alcoholic beverages, and
baked and fried foods. For more information, please visit our website at
www.functionaltechcorp.com.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Functional Technologies Corp.
Chris Morris
Interim CEO
+1.604.648.2200
cmorris@functionaltechcorp.com
www.functionaltechcorp.com

1 Year Functional Technologies Corp. Chart

1 Year Functional Technologies Corp. Chart

1 Month Functional Technologies Corp. Chart

1 Month Functional Technologies Corp. Chart

Your Recent History

Delayed Upgrade Clock